All Memorial Sloan Kettering Cancer Center articles
-
NewsResearch links tumor bacteria to immunotherapy resistance in head and neck cancer
Two new studies reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
-
NewsCombining laboratory techniques yields wealth of information about deadly brain tumors
In a new study, researchers injected into the tumor a virus aimed at killing glioblastoma cells. Surgeons took tumor tissue samples and ran them through multiple advanced laboratory techniques to demonstrate that even small tissue samples can yield additional insights.
-
NewsDigging into a decades-old hepatitis B mystery suggests a new potential treatment
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens the door to new treatments.
-
NewsNew evidence for a connection between antibiotic use and autoimmune diseases
A new connection has been revealed between depletion of gut bacteria caused by antibiotics and development of autoimmune diseases. Clearance of dead cells involves not only local signals from within a tissue but also distant signals from other parts of the body.
-
NewsResearchers discover source of deadly fungal infections in bone marrow transplant patients
Scientists have found that heteroresistance is the reason a small number of transplant patients developed bloodstream infections, despite receiving prophylaxis with the antifungal drug micafungin.
-
NewsSARS-CoV-2 can infect dopamine neurons, causing senescence
A new study has reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence - when a cell loses the ability to grow and divide.
-
News Crowd-sourced potent SARS-CoV-2 antiviral lead compound announced by COVID Moonshot Consortium
More than 200 scientists and students, triggered by a Twitter appeal, have identified and developed novel compounds with excellent antiviral activity against a key enzyme of the SARS-COV-2 virus, the main protease (Mpro).